Correlation Between Day One and Nuvectis Pharma

Can any of the company-specific risk be diversified away by investing in both Day One and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Day One Biopharmaceuticals and Nuvectis Pharma, you can compare the effects of market volatilities on Day One and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Nuvectis Pharma.

Diversification Opportunities for Day One and Nuvectis Pharma

0.8

Correlation Coefficient

Day One  Nuvectis Pharma

Very poor diversification

The 3 months correlation between Day and Nuvectis is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Day One i.e., Day One and Nuvectis Pharma go up and down completely randomly.

Pair Corralation between Day One and Nuvectis Pharma

Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to generate 0.25 times more return on investment than Nuvectis Pharma. However, Day One Biopharmaceuticals is 3.93 times less risky than Nuvectis Pharma. It trades about -0.29 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about -0.28 per unit of risk. If you would invest  1,639  in Day One Biopharmaceuticals on September 9, 2024 and sell it today you would lose (264.00) from holding Day One Biopharmaceuticals or give up 16.11% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Day One Biopharmaceuticals  vs.  Nuvectis Pharma

Day One Biopharmaceu

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Nuvectis Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nuvectis Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest conflicting performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Pair Trading with Day One and Nuvectis Pharma

The main advantage of trading using opposite Day One and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.

The idea behind Day One Biopharmaceuticals and Nuvectis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.